FindTrial
Sign In

The clinical value of small residual lesions detection of cervical cancer based on HPV ctDNA-prospective observational study

The clinical value of small residual lesions detection of cervical cancer based on HPV ctDNA-prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070819
Enrollment
Unknown
Registered
2023-04-24
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Initial surgical treatment:None
Initial synchronous chemoradiotherapy group:None

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1: The patient was at least 18 years old; 2: Pathological diagnosis: cervical squamous cell carcinoma, adenocarcinoma or adeno-squamous cell carcinoma; 3: FIGO (2018) stage: IA2-IIA1; 4: HPV typing: 16 or 18; 5: ECOG 0-2; 6: The initial treatment is surgical treatment

Exclusion criteria

Exclusion criteria: 1: Other malignant tumors within 3 years prior to the diagnosis of cervical cancer 2: Pregnant or lactating women 3: Refuse to sign the informed consent

Design outcomes

Primary

MeasureTime frame
Disease-free survival, DFS;—

Secondary

MeasureTime frame
HPV ctDNA;Overall Survival, OS;—

Countries

China

Contacts

Public ContactYiFeng Wang

Zhujiang Hospital of Southern Medical University

wyf1988@163.com+86 13825013170

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026